Clinical Trial Update: Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose radiotherapy for COVID-19 pneumonia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Low-Dose Radiotherapy

Snippet

Sponsor: Ohio State University | Conditions: Covid-19, Sars-CoV2 | Phase 2 | Status: ACTIVE_NOT_RECRUITING